224 related articles for article (PubMed ID: 18469113)
1. Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone.
Homma N; Nagaoka T; Karoor V; Imamura M; Taraseviciene-Stewart L; Walker LA; Fagan KA; McMurtry IF; Oka M
Am J Physiol Lung Cell Mol Physiol; 2008 Jul; 295(1):L71-8. PubMed ID: 18469113
[TBL] [Abstract][Full Text] [Related]
2. Fluoxetine inhibits monocrotaline-induced pulmonary arterial remodeling involved in inhibition of RhoA-Rho kinase and Akt signalling pathways in rats.
Wang HM; Wang Y; Liu M; Bai Y; Zhang XH; Sun YX; Wang HL
Can J Physiol Pharmacol; 2012 Nov; 90(11):1506-15. PubMed ID: 23181278
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of aloperin on monocroline-induced pulmonary hypertension via regulation of Rho A/Rho kinsase pathway in rats.
Wu F; Yao W; Yang J; Zhang M; Xu Y; Hao Y; Yan L; Niu Y; Sun T; Yu J; Zhou R
Biomed Pharmacother; 2017 Nov; 95():1161-1168. PubMed ID: 28926926
[TBL] [Abstract][Full Text] [Related]
4. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
[TBL] [Abstract][Full Text] [Related]
5. Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.
Paulin R; Meloche J; Jacob MH; Bisserier M; Courboulin A; Bonnet S
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1798-809. PubMed ID: 21890685
[TBL] [Abstract][Full Text] [Related]
6. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
7. [Expression and activity of RhoA/Rho kinase in remodeling of high blood flow pulmonary vessels.].
Li FH; Xia W; Sun RP
Zhonghua Er Ke Za Zhi; 2007 May; 45(5):387-92. PubMed ID: 17697629
[TBL] [Abstract][Full Text] [Related]
8. Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension.
Alzoubi A; Toba M; Abe K; O'Neill KD; Rocic P; Fagan KA; McMurtry IF; Oka M
Am J Physiol Heart Circ Physiol; 2013 Jun; 304(12):H1708-18. PubMed ID: 23585128
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
Liu WH; Xu XH; Luo Q; Zhang HL; Wang Y; Xi QY; Zhao ZH; Liu ZH
Clin Exp Hypertens; 2018; 40(3):224-230. PubMed ID: 29319354
[TBL] [Abstract][Full Text] [Related]
10. Rho kinase-mediated vasoconstriction in pulmonary hypertension.
McMurtry IF; Abe K; Ota H; Fagan KA; Oka M
Adv Exp Med Biol; 2010; 661():299-308. PubMed ID: 20204738
[TBL] [Abstract][Full Text] [Related]
11. RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling.
Guilluy C; Eddahibi S; Agard C; Guignabert C; Izikki M; Tu L; Savale L; Humbert M; Fadel E; Adnot S; Loirand G; Pacaud P
Am J Respir Crit Care Med; 2009 Jun; 179(12):1151-8. PubMed ID: 19299501
[TBL] [Abstract][Full Text] [Related]
12. KMUP-1 ameliorates monocrotaline-induced pulmonary arterial hypertension through the modulation of Ca2+ sensitization and K+-channel.
Dai ZK; Cheng YJ; Chung HH; Wu JR; Chen IJ; Wu BN
Life Sci; 2010 May; 86(19-20):747-55. PubMed ID: 20303989
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
Li FH; Xia W; Li AW; Zhao CF; Sun RP
Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
Li XL; Guan RJ; Li JJ
J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772
[TBL] [Abstract][Full Text] [Related]
15. Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension.
Li XH; Peng J; Tan N; Wu WH; Li TT; Shi RZ; Li YJ
Vascul Pharmacol; 2010; 53(5-6):223-9. PubMed ID: 20840872
[TBL] [Abstract][Full Text] [Related]
16. Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat.
Nagaoka T; Gebb SA; Karoor V; Homma N; Morris KG; McMurtry IF; Oka M
J Appl Physiol (1985); 2006 Mar; 100(3):996-1002. PubMed ID: 16322374
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of hypoxia-inducible factor-1α in proliferating neointimal lesions in a rat model of pulmonary arterial hypertension.
Yan J; Shen Y; Wang Y; Li BB
Am J Med Sci; 2013 Feb; 345(2):121-8. PubMed ID: 22627259
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of 18β-glycyrrhetinic acid on pulmonary arterial hypertension via regulation of Rho A/Rho kinsase pathway.
Zhang M; Chang Z; Zhang P; Jing Z; Yan L; Feng J; Hu Z; Xu Q; Zhou W; Ma P; Hao Y; Zhou R
Chem Biol Interact; 2019 Sep; 311():108749. PubMed ID: 31325423
[TBL] [Abstract][Full Text] [Related]
19. The beneficial effect of suramin on monocrotaline-induced pulmonary hypertension in rats.
Izikki M; Mercier O; Lecerf F; Guin LL; Hoang E; Dorfmüller P; Perros F; Humbert M; Simonneau G; Dartevelle P; Fadel E; Eddahibi S
PLoS One; 2013; 8(10):e77073. PubMed ID: 24143201
[TBL] [Abstract][Full Text] [Related]
20. Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension.
Desbuards N; Antier D; Rochefort GY; Apfeldorfer CS; Schenck E; Hanton G; Hyvelin JM
Eur J Pharmacol; 2009 Jan; 602(2-3):355-63. PubMed ID: 19049806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]